Literature DB >> 1819699

Synthesis of a PAF immunogen and production of PAF-specific antibodies.

M A Smal1, B A Baldo, J W Redmond.   

Abstract

Platelet activating factor (PAF), a naturally occurring phospholipid with many potent physiological and pharmacological activities, is implicated as a mediator of many diseases. An immunoassay for PAF would greatly improve quantitation, and hence PAF-specific antibodies were required. Chemically-reactive analogs of PAF, containing an aldehyde group at the end of the 1-O-alkyl chain (hexyl or dodecyl), were synthesized from readily available materials. During the multi-step synthetic procedure, the aldehyde group was protected as an acetal, which was converted by mild acidic hydrolysis to the aldehyde immediately prior to protein coupling. These analogs were coupled to methylated bovine serum albumin and the resultant conjugates were injected into rabbits. Antibodies to PAF were detected using a solid phase radioimmunoassay based on Protein A-Sepharose. The dodecyl PAF conjugate proved to be the more immunogenic conjugate with more than half of the rabbits producing significant levels of antibodies (at least a 10-fold increase in radioactive uptake over pre-immune levels). Results from solid phase immunoassays employing nitrocellulose discs impregnated with PAF, lysoPAF, lecithin, lysolecithin and 2-O-methyl-lysoPAF indicated that the antibodies recognized only PAF. PAF-specific antibodies were isolated by affinity chromatography using a column of PAF-poly(lysine) conjugated to carboxy-activated polyacrylamide. The antibodies may be employed in a sensitive and specific immunoassay for PAF and for many other studies involving PAF.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1819699     DOI: 10.1007/BF02536516

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  25 in total

Review 1.  Chemical and biochemical aspects of platelet activating factor: a novel class of acetylated ether-linked choline-phospholipids.

Authors:  F Snyder
Journal:  Med Res Rev       Date:  1985 Jan-Mar       Impact factor: 12.944

Review 2.  Platelet activating factor: a biologically active phosphoglyceride.

Authors:  D J Hanahan
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

Review 3.  Platelet-activating factor and the kidney.

Authors:  D Schlondorff; R Neuwirth
Journal:  Am J Physiol       Date:  1986-07

Review 4.  The role of platelet-activating factor in asthma.

Authors:  C P Page
Journal:  J Allergy Clin Immunol       Date:  1988-01       Impact factor: 10.793

Review 5.  Perspectives in platelet-activating factor research.

Authors:  P Braquet; L Touqui; T Y Shen; B B Vargaftig
Journal:  Pharmacol Rev       Date:  1987-06       Impact factor: 25.468

Review 6.  Platelet-activating factor as a mediator of allergic disease.

Authors:  P J Barnes; K F Chung; C P Page
Journal:  J Allergy Clin Immunol       Date:  1988-05       Impact factor: 10.793

7.  A lethal role of platelet activating factor in anaphylactic shock in mice.

Authors:  Z Terashita; Y Imura; A Shino; K Nishikawa
Journal:  J Pharmacol Exp Ther       Date:  1987-10       Impact factor: 4.030

8.  Isolation of a platelet membrane protein which binds the platelet-activating factor 1-0-hexadecyl-2-acetyl-SN-glycero-3-phosphorylcholine.

Authors:  F H Valone
Journal:  Immunology       Date:  1984-05       Impact factor: 7.397

9.  In vivo inhibition of plasma protein leakage and Salmonella enteritidis-induced mortality in the rat by a specific paf-acether antagonist: BN 52021.

Authors:  A Etienne; F Hecquet; C Soulard; B Spinnewyn; F Clostre; P Braquet
Journal:  Agents Actions       Date:  1986-01

10.  Antibody to platelet activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine; PAF).

Authors:  K Karasawa; K Fujita; N Satoh; T Hongo; M Setaka; M Ohno; S Nojima
Journal:  J Biochem       Date:  1987-09       Impact factor: 3.387

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.